生体吸収ステントの市場規模、シェア、成長分析、製品タイプ別、吸収率別、用途別、地域別 - 産業予測、2025-2032年

生体吸収ステント市場規模は2023年に25億6,000万米ドルと評価され、2024年の27億9,000万米ドルから2032年には55億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.9％で成長する見通しです。

世界の生体吸収ステント市場は、高齢化と心血管疾患有病率の上昇を原動力に大きく成長する見通しです。冠動脈疾患の増加は、経皮的冠動脈形成術（PCI）手技の上昇につながり、患者とヘルスケアプロバイダーの両方による生体吸収ステントの採用を拡大しています。技術の進歩と低侵襲治療へのシフトが市場拡大をさらに後押ししています。技術革新を促進する開発イニシアティブと有利な規制が、生体吸収ステントの開発を促進しています。しかし、処置にかかる高額な費用やこれらのステントに伴う潜在的なリスクなどの課題は、成長を阻害する可能性があります。全体として、人口動態の変化、技術の進歩、政府の支援策が市場の将来軌道を形成する上で重要な役割を果たします。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

生体吸収ステント市場規模：製品タイプ別

• 市場概要
• ポリマーベース生体吸収ステント
• メタルベース生体吸収ステント

生体吸収ステント市場規模：吸収率別

• 市場概要
• 低速吸収ステント
• 高速吸収ステント

生体吸収ステント市場規模：ポリマーベース生体吸収ステント別

• 市場概要
• ポリ（乳酸-グリコール酸）ステント
• ポリグリコール酸ステント
• ポリ（L-乳酸）ステント
• その他の生分解性ポリマーステント

生体吸収ステント市場規模：メタルベース生体吸収ステント別

• 市場概要
• マグネシウムベースのステント
• 鉄べースのステント
• 亜鉛ベースのステント
• その他のメタルベース生体吸収ステント

生体吸収ステント市場規模：用途別

• 市場概要
• 冠動脈疾患
• 末梢動脈疾患

生体吸収ステント市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Boston Scientific Corporation（USA）
• Arterius Limited（UK）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Terumo Corporation（Japan）
• Elixir Medical Corporation（USA）
• Abbott Laboratories Inc.（USA）
• Amaranth Medical（USA）
• Biotronik（Germany）
• Meril Life Sciences Pvt. Ltd.（India）
• Reva Medical（USA）
• Svelte Medical Systems（USA）
• Lepu Medical Technology Co., Ltd.（China）
• Medtronic plc（Ireland）
• B. Braun Melsungen AG（Germany）
• MicroPort Scientific Corporation（China）
• Cardionovum GmbH（Germany）
• Biotronik SE & Co. KG（Germany）
• ICON Interventional Systems（USA）
• Arterial Remodeling Technologies（France）
• Elixir Medical Corporation（USA）

結論と提言

Bioabsorbable Stents Market size was valued at USD 2.56 billion in 2023 and is poised to grow from USD 2.79 billion in 2024 to USD 5.51 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global bioabsorbable stents market is poised for significant growth driven by an aging population and escalating cardiovascular disease prevalence. The rise in coronary artery disease has led to an uptick in percutaneous coronary intervention (PCI) procedures, amplifying the adoption of bioabsorbable stents by both patients and healthcare providers. Technological advancements and a shift towards minimally invasive treatments further boost market expansion. Government initiatives promoting innovation and favorable regulations enhance the development of bioabsorbable stents. However, challenges such as the high cost of procedures and potential risks associated with these stents could impede growth. Overall, demographic shifts, technological progress, and supportive government measures will play crucial roles in shaping the market's future trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioabsorbable Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioabsorbable Stents Market Segments Analysis

Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioabsorbable Stents Market

The Bioabsorbable Stents market is significantly driven by advancements in design and technology, which have accelerated the treatment of coronary artery disease with biodegradable stents. These innovative stents are crafted from biodegradable polymers that safely dissolve after fulfilling their purpose, enhancing patient outcomes. Research by the U.S. FDA has highlighted the potential of these stents to mitigate late-stage complications, such as stent thrombosis. As a result, there is an increased patient acceptance and utilization, fostering wider market adoption and positioning bioabsorbable stents as a promising solution in cardiovascular care, effectively addressing a critical healthcare need for safer and more effective treatments.

Restraints in the Bioabsorbable Stents Market

The bioabsorbable stents market faces significant challenges due to concerns surrounding the long-term efficacy and safety of these devices. Healthcare providers remain skeptical, particularly following complications linked to several first-generation models, such as late stent thrombosis and restenosis, which have cast doubts on their clinical performance. These issues have negatively impacted market confidence, leading clinicians to advocate for more extensive clinical trials and the development of improved device designs. To regain trust in bioabsorbable stent technology, it is essential to establish enhanced safety profiles and provide comprehensive long-term data demonstrating their reliability and effectiveness in patient care.

Market Trends of the Bioabsorbable Stents Market

The bioabsorbable stents market is experiencing a significant trend towards the development of innovative materials aimed at enhancing clinical outcomes. Researchers are focusing on creating advanced composite materials that provide superior biocompatibility, increased mechanical strength, and optimized degradation rates. These improvements are designed to address the limitations of existing stent materials, ultimately leading to better patient outcomes and performance. This market shift highlights a commitment to enhancing the durability and long-term efficacy of bioabsorbable stents, thereby minimizing complications and bolstering the overall efficacy of cardiac interventions. As a result, growth in this segment is expected to accelerate significantly in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Bioabsorbable Stents Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Polymer-Based Bioabsorbable Stents
• Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Absorption Rate & CAGR (2025-2032)

• Market Overview
• Slow-Absorption Stents
• Fast-Absorption Stents

Global Bioabsorbable Stents Market Size by Polymer-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents
• PGA (Polyglycolic Acid) Stents
• PLLA (Poly (L-Lactic Acid)) Stents
• Other Biodegradable Polymer Stents

Global Bioabsorbable Stents Market Size by Metal-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• Magnesium-Based Stents
• Iron-Based Stents
• Zinc-Based Stents
• Other Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Diseases
• Peripheral Artery Diseases

Global Bioabsorbable Stents Market Size & CAGR (2025-2032)

• North America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • US
  • Canada
• Europe (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Svelte Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations